Nile Therapeutics CEO takes token pay in cash crunch; Vivo Ventures invests $30M in China company;

Conversation on Twitter :

 @FierceBiotech: From PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item | Follow @FierceBiotech

 @JohnCFierce: Buyout Buzz: The most frequently cited takeover targets in biotech. Special Report | Follow @JohnCFierce

 @RyanMFierce: Crowdsourcing kick spurs interest in NIH drug recycling. More | Follow @RyanMFierce

> The CEO at the tiny biotech Nile Therapeutics has slashed her pay to a token sum as the company scrambles to raise fresh funds. In a recent SEC filing Nile noted that it only had enough cash to make it through this month, according to a piece in the San Francisco Business Times. Story

> Vivo Ventures has invested $30 million in Shanghai Jingfeng Pharmaceutical. The move follows a decision to boost its investments in China with its seventh fund. Story

> Washington University researcher David Curiel has joined the scientific board at DNAtrix after merging his company with the Houston-based ovarian cancer drug developer. Story

Pharma News

@FiercePharma: Congressional hearings on the meningitis debacle to begin next week. FDA's Hamburg on the sked: Report | Follow @FiercePharma

> Teva shunts Americas chief aside in management shuffle. Article

> Bristol-Myers to slash 480 sales-related jobs in NJ. Story

> AbbVie raises $14.7B for spinoff in record bond issue. News

Medical Device News

 @FierceMedDev: After another quarterly slide, Wright Medical is planning to reorganize. Report | Follow @FierceMedDev

 @MarkHFierce: FDA warns the maker of a light therapy product designed to treat fungal meningitis that the product is unapproved. More | Follow @MarkHFierce

 @DamianFierce: Myriad Genetics is raising its full-year guidance after a strong quarter. More | Follow @DamianFierce

> FDA cites Tennessee company for meningitis light therapy device. Item

> St. Jude chases renal denervation market share with new study. Report

Biotech Research News

> Failed AstraZeneca drugs gain second chance with $11M U.K. program. News

> UC Davis team finds new lung cancer Rx target. Article

> 'Abdominal imaging window' lets researchers crack cancer metastasis secrets. Story

> Scientists wield stem cells to undo male infertility inflicted by cancer treatment in monkeys. More

Pharma Manufacturing News

> India's price-setting agency prepares for plant inspections. Story

> Sigma-Aldrich gets foothold in S. Korea with API deal. Article

> German Bayer partners with Russian drug manufacturer. News

And Finally… New research underscores the idea that some commonly used medications can trigger serious memory loss. Release


Suggested Articles

Novartis unveiled more data showing how its asthma combo QMF149 fared against the standard of care: a combination of the same types of drugs.

Johns Hopkins researchers developed a biodegradable polymer to transport large therapies into cells—including genes and even CRISPR.

UCB’s bispecific antibody recently beat Johnson & Johnson’s Stelara at clearing psoriasis symptoms, and now it has bested AbbVie’s Humira, too.